Navigation Links
Rare Womens Lung Disease May Yield Insights Into Common Diseases

For many decades, medical research studies focused primarily on men and the results of countless studies were then applied to women. But we now know that the biological sex and gender differences between men and women are more than skin deep. Beginning in 1990, the Society for Womens Health Research, a Washington, D.C., based advocacy organization, conveyed to a national audience the need for including women in biomedical research studies. Today, research on women is robust.

Biomedical research can make an enormous difference in the lives of women. Take Dr. Elizabeth Petri Henske, M.D., the recipient of the 2007 Society for Womens Health Research Medtronic Prize for Scientific Contributions to Womens Health. The prize was established to recognize a women scientist or engineer for her contributions to womens health and encourage women to work on issues uniquely related to womens health.

Henske is an oncologist at the Fox Chase Cancer Center in Philadelphia, Pa. Her work focuses on the genetic and cellular mechanisms leading to two diseases not well-known to the public: tuberous sclerosis complex (TSC) and lymphangioleiomyomatosis (LAM).

LAM is a lung disease that almost exclusively affects young women. LAM has a stronger female predisposition than lupus or breast cancer, and may have the strongest biological sex predisposition of any human disease, except for diseases of the genital organs, and it is often fatal. Scientists estimate that there could be as many as 250,000 LAM patients worldwide.

LAM affects young women, and can strike suddenly during pregnancy, Henske said. LAM causes the lungs to fill with abnormal cells. As a result, cysts or holes can develop in the lung, causing it to collapse. The disease takes a major toll on the body, making even mundane tasks difficult. Women with LAM often need oxygen, are continuously short of breath, and are unable care for their children or walk up a flight of stairs , Henske said. Many women with LAM die prematurely.

As part of her work, Henske discovered that mutations in the tuberous sclerosis gene, which triggers TSC, a genetic disorder that causes tumors to form in many different organs, including the brain, eyes, heart, kidney, skin and lungs, plays a role in the cause of LAM. Her current work involves looking into the role female hormones play in the growth and metastasis of LAM cells.

Her tireless efforts have shed light on the connection between two diseases, provided understanding of the underlying mechanisms and hopefully will one day lead to a cure. By studying LAM we hope to develop treatments to eradicate LAM cells, and also learn more about how hormones cause abnormal cells to grow and metastasize, Henske said.

Henskes work may also benefit research on common diseases because the cellular pathways that are activated in tuberous sclerosis and LAM are also activated in many forms of cancer, and in diabetes and obesity. What is learned about LAM may help us understand more common diseases in which hormones play an important role, such as breast cancer. The impact of LAM research could spread to other diseases that are not hormonally dependent, she points out.

Despite the current advances being made by researchers like Henske, there is still an enormous amount that we do not yet understand about sex and gender differences in health and disease, ground that will hopefully be covered by researchers in the future.


'"/>




Related medicine news :

1. Cosmetic Genital Surgery may Be Fuelling Womens Insecurity About Their Bodies
2. Diabetic Womens Death Rate Shows No Decline
3. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
4. Vitamins-The answer to Heart Disease?
5. Link between Constipation and Parkinsons Disease
6. Levels Of Blood Proteins May Help Heart Disease Care
7. New Drug PP188 Helps Sickle Cell Disease
8. Gene Treatment for Heart Disease
9. Legume Consumption Can Cut Heart Disease Risk
10. Link Between Infection And Heart Disease
11. Celiac Disease in Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's ... President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. ... 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the role ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps ... provides a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... 2017 , ... Coveros, a leader in agile coaching services ... by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile Transformation ... Agile methodologies in a consistent and high value manner across CMS programs. Coveros ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/22/2017)... Sept. 22, 2017 AVACEN Medical (AVACEN) announced ... now successfully helping those with the widespread pain associated ... diagnosed Amanda in Essex, England ... my hair, experiencing no sleep at all, tremendous pain, ... I cannot recommend [the AVACEN 100] enough, how this ...
Breaking Medicine Technology: